1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Exelixis, Inc.

Exelixis, Inc.

EXEL
Exelixis, Inc.US flagNASDAQ Global Select
51.60
USD
+3.06
- -
12.97BMarket Cap

Total Valuation

Exelixis, Inc. carries a market capitalization of 12.97B, placing it among publicly traded companies globally. Its enterprise value stands at 10.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap12.97B
Enterprise Value10.82B

Share Statistics

Exelixis, Inc. currently has 253.70M shares outstanding.

Shares Outstanding253.70M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Exelixis, Inc. trades at a trailing price-to-earnings ratio of 13.71. The price-to-sales ratio is 4.81, and the price-to-book ratio stands at -53.02.

PE Ratio13.71
PS Ratio4.81
PB Ratio-53.02
P/TBV Ratio6.10
P/FCF Ratio12.57
P/OCF Ratio12.36

Enterprise Valuation

On an enterprise value basis, Exelixis, Inc. trades at an EV/EBITDA multiple of 10.98 and an EV/FCF ratio of 11.46. The EV/Sales ratio of 4.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.30 provides insight into valuation relative to core operating earnings.

EV / Sales4.55
EV / EBITDA10.98
EV / EBIT11.30
EV / FCF11.46

Financial Position

Exelixis, Inc. maintains a current ratio of 3.26, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.

Current Ratio3.26
Quick Ratio2.98
Debt / Equity8.76
Debt / EBITDA0.17
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)30.69
Return on Invested Capital (ROIC)35.95
Return on Capital Employed (ROCE)-7,613.58
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.28

Taxes

Over the trailing twelve months, Exelixis, Inc. has paid 169.78M in income taxes, reflecting an effective tax rate of 16.92.

Income Tax169.78M
Effective Tax Rate16.92

Stock Price Statistics

Exelixis, Inc.'s stock has gained approximately 20.92805% over the past 52 weeks. The 50-day moving average sits at 46.21, while the 200-day moving average is 42.62.

Beta (5Y)N/A
52-Week Price Change20.92805%
50-Day Moving Average46.21
200-Day Moving Average42.62
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Exelixis, Inc. generated 2.38B in revenue and converted that into 833.42M in net income, yielding earnings per share of 3.01. EBITDA reached 985.84M, while operating income came in at 957.18M.

Revenue2.38B
Gross Profit2.29B
Operating Income957.18M
Pretax Income1.00B
Net Income833.42M
EBITDA985.84M
EBIT957.18M
Earnings Per Share (EPS)3.01

Balance Sheet

Exelixis, Inc. holds 777.21M in cash and equivalents against 169.54M in total debt, resulting in a net debt position of -226.15M. Total book value stands at -215.54M, with working capital of 837.66M providing operational flexibility.

Cash & Cash Equivalents777.21M
Total Debt169.54M
Net Debt-226.15M
Equity (Book Value)-215.54M
Book Value Per Share-0.81
Working Capital837.66M

Cash Flow

Exelixis, Inc. produced 924.68M in operating cash flow over the past twelve months. After subtracting -19.51M in capital expenditures, free cash flow totaled 905.17M - equivalent to 3.40 per share.

Operating Cash Flow924.68M
Capital Expenditures-19.51M
Free Cash Flow905.17M
FCF Per Share3.40

Margins

Exelixis, Inc. operates with a gross margin of 96.44, reflecting its pricing power and cost economics. The operating margin of 40.29 and net profit margin of 35.08 provide insight into operational efficiency.

Gross Margin96.44
Operating Margin40.29
Pretax Margin42.23
Profit Margin35.08
EBITDA Margin41.50

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield9.90
FCF Yield7.96

Scores

Exelixis, Inc. posts an Altman Z-Score of 12.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score12.89